A new targeted therapy for hard-to-treat chronic lymphocytic leukemia appears to have fewer side effects than a previous therapy.
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.
A drug that boosts activity in the brain’s “garbage disposal” system can decrease levels of toxic proteins associated with Alzheimer’s disease and other neurodegenerative disorders and improve cognition in mice.
Nanofiber technology developed at Columbia may improve healing of the tendon-to-bone interface, the weak link in current rotator cuff repairs.
Celebrates acknowledges faculty, staff, and students at CUMC who receive major research grants or earn prestigious honors, as well as gifts made by donors.
View some of the top videos produced this year to highlight CUMC research and education news.
Among this year's highlights are a building topping-off, a White House collaboration, connections made through art, and a research project with implications for campuses at Columbia and beyond.
P&S researcher Dritan Agalliu, PhD, finds pathway by which recurrent strep infections may lead to autoimmune psychiatric disorders.
Review some of the year's top stories about research at Columbia University Medical Center's four schools.
P&S researcher, Donna Farber, PhD, discovers fundamental characteristics of infant immune system and development.
Mailman professor Dale Hesdorffer examines association between epilepsy and suicidal behavior, strengthening evidence of an underlying commonality.